[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100529003":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":12,"locations":18,"responsibleParty":33,"collaborators":7,"id":37,"slug":7,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":45,"enrollmentInfo":46,"targetDuration":49,"studyType":50,"phases":7,"briefSummary":51,"conditions":52,"keywords":7,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"St. Antonius Hospital","OTHER",null,[9],{"type":10,"name":11,"description":11,"armGroupLabels":7,"otherNames":7},"BEHAVIORAL","Quality of life questionnaires will be assessed in addition to standard care",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Christiaan Overduin","CONTACT","+31 (0)88 320 0931","c.overduin@antoniusziekenhuis.nl",[19],{"facility":5,"status":20,"city":21,"state":7,"zip":7,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"RECRUITING","Nieuwegein","Netherlands","NL",{"type":25,"coordinates":26},"Point",[27,28],5.08056,52.02917,{"lat":28,"lon":27},[31],{"name":32,"role":15,"phone":7,"phoneExt":7,"email":7},"Jurrien ten berg, MD PhD",{"type":34,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Jurriën M. ten Berg, MD, PhD","Clinical Professor","100529003",false,"NCT06168123","Future Optimal Research and Care Evaluation - Aortic Stenosis","FORCE-AoS","Inclusion Criteria:\n\n* Older than 18 years of age\n* Severe or moderate aortic stenosis\n\nNo exclusion criteria are applicable to this registry","ALL","18 Years","110 Years",{"count":47,"type":48},800,"ESTIMATED","4 Years","OBSERVATIONAL","In the past decade the treatment of aortic valve stenosis has rapidly changed. At first, transcatheter aortic valve implantation (TAVI) was a last resort option for inoperable patients. Nowadays, it more and more becomes an alternative to surgical aortic valve replacement (SAVR) - also in younger and lower risk patients. This poses important questions to clinical practise regarding the optimal life-time management of each individual patient. Which involves (durability of) treatment modality (surgical vs. transcatheter vs. conservative treatment) as well as the duration and type of the required antithrombotic treatment.\n\nObjective: to evaluate the effect of treatment modality (surgical vs. transcatheter vs. conservative treatment) and its complications on quality of life and survival in AoS patients.",[53,54],"Severe Aortic Valve Stenosis","Moderate Aortic Valve Stenosis","2024-11-28",{"date":57,"type":58},"2024-12-03","ACTUAL",{"date":60,"type":58},"2023-11-27",{"date":62,"type":48},"2027-08-01",{"name":5,"class":6},1]